Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy
NCT00164840
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
244
Enrollment
OTHER
Sponsor class
Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG:
Esomeprazole
Sponsor
Chinese University of Hong Kong